ImportantUpdates

Kilitch Drugs has shared its FY25-26 Annual Report web-link with relevant shareholders and announced its 34th AGM via VC.

Kilitch Drugs (India) Limited logo
Kilitch Drugs (India) LimitedKILITCH · Filed with the exchange

Investors are urged to update KYC details and dematerialize physical securities, crucial for continued electronic payments and compliance.

Read the original filing(PDF)

No comments yet. Be the first.

More from Kilitch Drugs (India) Limited

All announcements